Chimeric antigen receptor-modified T cell therapy in chronic lymphocytic leukemia
Chimeric antigen receptor-modified T cell therapy in chronic lymphocytic leukemia
About this item
Full title
Author / Creator
Zou, Yixin , Xu, Wei and Li, Jianyong
Publisher
England: BioMed Central
Journal title
Language
English
Formats
Publication information
Publisher
England: BioMed Central
Subjects
More information
Scope and Contents
Contents
Chronic lymphocytic leukemia (CLL), a common type of B cell chronic lymphoproliferative disorder in adults, has witnessed enormous development in its treatment in recent years. New drugs such as ibrutinib, idelalisib, and venetoclax have achieved great success in treating relapsed and refractory (R/R) CLL. In addition, with the development of immun...
Alternative Titles
Full title
Chimeric antigen receptor-modified T cell therapy in chronic lymphocytic leukemia
Authors, Artists and Contributors
Author / Creator
Identifiers
Primary Identifiers
Record Identifier
TN_cdi_doaj_primary_oai_doaj_org_article_97426f185bf449538e8ad72bd70a7828
Permalink
https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_doaj_primary_oai_doaj_org_article_97426f185bf449538e8ad72bd70a7828
Other Identifiers
ISSN
1756-8722
E-ISSN
1756-8722
DOI
10.1186/s13045-018-0676-3
